Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

Long-term patient-important outcomes after septic shock: a protocol for 1-year follow-up of the CLASSIC-trial

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


  1. Long-term IV access in paediatrics - why, what, where, who and how

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Preferences for the measurement and supplementation of magnesium, phosphate and zinc in ICUs: The international WhyTrace survey

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Continuous peripheral perfusion index in patients admitted to hospital wards - An observational study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND: In patients with septic shock, mortality is high, and survivors experience long-term physical, mental and social impairments. The ongoing Conservative vs Liberal Approach to fluid therapy of Septic Shock in Intensive Care (CLASSIC) trial assesses the benefits and harms of a restrictive vs standard-care intravenous (IV) fluid therapy. The hypothesis is that IV fluid restriction improves patient-important long-term outcomes.

AIM: To assess the predefined patient-important long-term outcomes in patients randomised into the CLASSIC trial.

METHODS: In this pre-planned follow-up study of the CLASSIC trial, we will assess all-cause mortality, health-related quality of life (HRQoL) and cognitive function 1 year after randomisation in the two intervention groups. The 1-year mortality will be collected from electronic patient records or central national registries in most participating countries. We will contact survivors and assess EuroQol 5-Dimension, -5-Level (EQ-5D-5L) and EuroQol-Visual Analogue Scale and Montreal Cognitive Assessment 5-minute protocol score. We will analyse mortality by logistic regression and use general linear models to assess HRQoL and cognitive function.

DISCUSSION: With this pre-planned follow-up study of the CLASSIC trial, we will provide patient-important data on long-term survival, HRQoL and cognitive function of restrictive vs standard-care IV fluid therapy in patients with septic shock.

TidsskriftActa Anaesthesiologica Scandinavica
Sider (fra-til)410–416
StatusUdgivet - 2020

Bibliografisk note

© 2019 The Acta Anaesthesiologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

ID: 58627727